Skip to main content



Influential in their field

15.11.2023 / Sofia Forslund, Friedemann Paul, and Nikolaus Rajewsky are among the Highly Cited Researchers 2023. Each year the company Clarivate compiles a "Who's Who" list of highly influential researchers.

When a seminal study is published in a scientific journal, researchers worldwide reference it, citing the work and, in turn, providing a measure of the authors' scientific impact. This is the basis for the "Highly Cited Researchers" list. The ranking includes studies from the past decade that have been cited the most within their respective fields and publication years, representing the top percentile. Clarivate Analytics, a US-based company specializing in bibliometrics and data science, doesn't rely solely on numbers; they combine quantitative and qualitative analyses to compile a "Who's Who" in research.

Approximately one in a thousand researchers makes it onto this prestigious list, and this year 6,849 researchers from 67 countries have achieved this recognition. The majority of them work in the United States of America (2,669), followed by scientists from China (1,275), the United Kingdom (574), and Germany (336) – like Professors Sofia Forslund, Friedemann Paul and Nikolaus Rajewsky.

About our researchers

Sofia Forslund heads a research group at the Experimental and Clinical Research Center (ECRC), a joint institution of Charité – Universitätsmedizin Berlin and the Max Delbrück Center. The data-driven models developed by the Swedish biochemist and bioinformatician illustrate how we and our gut microbiome develop together toward health or disease.

Friedemann Paul is Director of the ECRC. As a neuroimmunologist, he and his team focus on enhancing therapeutics and diagnostics for diseases such as Multiple Sclerosis. Additionally, they participate in an international consortium researching inflammatory processes preceding organ malfunction or damage.

Nikolaus Rajewsky, Director of the Berlin Institute for Medical Systems Biology at the Max Delbrück Center (MDC-BIMSB), aims to identify diseases using high-throughput single-cell analysis methods, intervening before cellular dysfunctions cause harm. To pave the way for cell-based medicine in Berlin and Europe, he actively works to establish networks at all levels.

Source: Press Release Max Delbrück Center
Influential in their field

Overview News